302 related articles for article (PubMed ID: 31537508)
1. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic cholestasis related to vanishing bile duct syndrome in Hodgkin's disease.
Gottrand F; Cullu F; Mazingue F; Nelken B; Lecomte-Houcke M; Farriaux JP
J Pediatr Gastroenterol Nutr; 1997 Apr; 24(4):430-3. PubMed ID: 9144127
[No Abstract] [Full Text] [Related]
3. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
[TBL] [Abstract][Full Text] [Related]
4. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen.
Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS
Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781
[TBL] [Abstract][Full Text] [Related]
5. Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature.
Nader K; Mok S; Kalra A; Harb A; Schwarting R; Ferber A
Tumori; 2013; 99(4):e164-8. PubMed ID: 24326854
[TBL] [Abstract][Full Text] [Related]
6. Vanishing bile duct syndrome and immunodeficiency preceding the diagnosis of Hodgkin lymphoma.
Yeh P; Lokan J; Anantharajah A; Grigg A
Intern Med J; 2014 Dec; 44(12a):1240-4. PubMed ID: 25442758
[TBL] [Abstract][Full Text] [Related]
7. Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy.
Leeuwenburgh I; Lugtenburg EP; van Buuren HR; Zondervan PE; de Man RA
Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):145-7. PubMed ID: 18188038
[TBL] [Abstract][Full Text] [Related]
8. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
[TBL] [Abstract][Full Text] [Related]
9. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
Hubscher SG; Lumley MA; Elias E
Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
[TBL] [Abstract][Full Text] [Related]
10. Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events.
Ishitsuka K; Yokoyama Y; Baba N; Matsuoka R; Sakamoto N; Sakamoto T; Kusakabe M; Kato T; Kurita N; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
J Clin Exp Hematop; 2022 Sep; 62(3):154-157. PubMed ID: 35831099
[TBL] [Abstract][Full Text] [Related]
11. Vanishing Bile Duct Syndrome in the Presence of Hodgkin Lymphoma.
Gaudel P; Brown P; Byrd K
Cureus; 2022 Jul; 14(7):e26842. PubMed ID: 35974868
[TBL] [Abstract][Full Text] [Related]
12. Vanishing Bile Duct Syndrome Secondary to Hodgkin Lymphoma in a Child.
Palla Velangini S; Boddu D; Balakumar S; Premanand A; Kishore R; Mathew LG
J Pediatr Hematol Oncol; 2022 Aug; 44(6):e945-e947. PubMed ID: 35796591
[TBL] [Abstract][Full Text] [Related]
13. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) in Hodgkin's disease: report of a case.
Guliter S; Erdem O; Isik M; Yamac K; Uluoglu O
Tumori; 2004; 90(5):517-20. PubMed ID: 15656342
[TBL] [Abstract][Full Text] [Related]
14. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
Xie W; Wang Q; Gao Y; Pan CQ
BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
[TBL] [Abstract][Full Text] [Related]
15. Vanishing bile duct syndrome temporally associated with ibuprofen use.
Alam I; Ferrell LD; Bass NM
Am J Gastroenterol; 1996 Aug; 91(8):1626-30. PubMed ID: 8759674
[TBL] [Abstract][Full Text] [Related]
16. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A
Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983
[TBL] [Abstract][Full Text] [Related]
17. Vanishing bile duct syndrome-related jaundice as the first presentation of Hodgkin lymphoma.
Mellat-Ardakani M; Salahshour F; Rafsanjani K; Avanaki FA; Azizi M
Radiol Case Rep; 2023 Sep; 18(9):3291-3294. PubMed ID: 37483375
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
[TBL] [Abstract][Full Text] [Related]
19. Meropenem-induced vanishing bile duct syndrome.
Schumaker AL; Okulicz JF
Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
Pusl T; Beuers U
World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
